1 | Acetate | [1] Acetate Acetate | - | - | - | [41] 1 1, 2, 6, 10, 13, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 171, 206, 222, 224, 225, 227, 235, 251, 265, 288, 298, 299 💬
|
2 | ALX-0081 | - | - | - | - | [1] 64 64 💬
|
3 | ALX0081 | - | - | - | - | [1] 64 64 💬
|
4 | Anfibatide | [1] Anfibatide Anfibatide | - | - | - | [1] 64 64 💬
|
5 | Anti-CD20 antibody | - | - | - | - | [1] 64 64 💬
|
6 | Anti-von Willebrand Factor Nanobody | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 64 64 💬
|
7 | Anti-von Willebrand Factor Nanobody, Caplacizumab | [2] Caplacizumab Caplacizumab, Von Willebrand factor human | [1] Caplacizumab
Caplacizumab
💬
| [1] VWF VWF 💬
| [8] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | [1] 64 64 💬
|
8 | Anti-von Willebrand Factor Nanobody, INN = Caplacizumab | [2] Caplacizumab Caplacizumab, Von Willebrand factor human | [1] Caplacizumab
Caplacizumab
💬
| [1] VWF VWF 💬
| [8] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | [1] 64 64 💬
|
9 | Apadamtase alfa | [1] Apadamtase alfa Apadamtase alfa | - | - | - | [1] 64 64 💬
|
10 | Apademtase alfa | - | - | - | - | [1] 64 64 💬
|
11 | ARC 1779 | - | - | - | - | [2] 64 64, 288 💬
|
12 | ARC1779 | - | - | - | - | [2] 64 64, 288 💬
|
13 | ARC1779 Injection | - | - | - | - | [2] 64 64, 288 💬
|
14 | Aspirin | [1] Acetylsalicylic acid Acetylsalicylic acid | [1] Aspirin
Aspirin
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [12] 13 13, 22, 46, 49, 51, 58, 64, 86, 113, 158, 210, 231 💬
|
15 | Aspirin tablet | [1] Acetylsalicylic acid Acetylsalicylic acid | [1] Aspirin
Aspirin
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 64 64 💬
|
16 | BAX930 | - | - | - | - | [1] 64 64 💬
|
17 | BAX930 - RECOMBINANT HUMAN ADAMTS13 | - | - | - | - | [1] 64 64 💬
|
18 | BAX930 or SHP655 | - | - | - | - | [1] 64 64 💬
|
19 | BAX930 or SHP655 or TAK755 | - | - | - | - | [1] 64 64 💬
|
20 | BORTEZOMIB | [2] Bortezomib Bortezomib, Bortezomib D-mannitol | [1] Bortezomib
Bortezomib
💬
| [1] PSMB5 PSMB5 💬
| [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [17] 11 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 222, 228, 256, 283, 288, 331 💬
|
21 | Bortezomib Injection | [1] Bortezomib Bortezomib | [1] Bortezomib
Bortezomib
💬
| [1] PSMB5 PSMB5 💬
| [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 64 64 💬
|
22 | CABLIVI | [1] Caplacizumab Caplacizumab | [1] Caplacizumab
Caplacizumab
💬
| [1] VWF VWF 💬
| [8] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | [1] 64 64 💬
|
23 | Cablivi® | [1] Caplacizumab Caplacizumab | [1] Caplacizumab
Caplacizumab
💬
| [1] VWF VWF 💬
| [8] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | [1] 64 64 💬
|
24 | CAPLACIZUMAB | [1] Caplacizumab Caplacizumab | [1] Caplacizumab
Caplacizumab
💬
| [1] VWF VWF 💬
| [8] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | [1] 64 64 💬
|
25 | Caplacizumab (ALX-0081) | [1] Caplacizumab Caplacizumab | [1] Caplacizumab
Caplacizumab
💬
| [1] VWF VWF 💬
| [8] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | [1] 64 64 💬
|
26 | Caplacizumab (an anti-von Willebrand Factor Nanobody ALX-0081) | [2] Caplacizumab Caplacizumab, Von Willebrand factor human | [1] Caplacizumab
Caplacizumab
💬
| [1] VWF VWF 💬
| [8] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | [1] 64 64 💬
|
27 | Caplacizumab (an anti-von Willebrand Factor Nanobody) | [2] Caplacizumab Caplacizumab, Von Willebrand factor human | [1] Caplacizumab
Caplacizumab
💬
| [1] VWF VWF 💬
| [8] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | [1] 64 64 💬
|
28 | Corticosteroid treatment (Methylprednisolone or prednisolone) | [2] Methylprednisolone Methylprednisolone, Prednisolone | [2] Methylprednisolone
Methylprednisolone
,
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 64 64 💬
|
29 | Corticosteroids | - | - | - | - | [12] 41 41, 46, 49, 63, 64, 97, 107, 113, 164, 220, 296, 300 💬
|
30 | Cryosupernatant plasma | - | - | - | - | [1] 64 64 💬
|
31 | Cyclosporine | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [37] 11 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 107, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬
|
32 | Danazol | [1] Danazol Danazol | [1] Danazol
Danazol
💬
| [3] AR AR, ESR1, PGR 💬
| [12] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [5] 60 60, 63, 64, 65, 285 💬
|
33 | Desmopressin | [1] Desmopressin Desmopressin | [1] Desmopressin
Desmopressin
💬
| [2] AVPR2 AVPR2, F8 💬
| [4] Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [5] 6 6, 64, 72, 225, 288 💬
|
34 | Desmopressin acetate | [2] Acetate Acetate, Desmopressin | [1] Desmopressin
Desmopressin
💬
| [2] AVPR2 AVPR2, F8 💬
| [4] Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [2] 64 64, 288 💬
|
35 | Dexamethasone | [1] Dexamethasone Dexamethasone | [1] Dexamethasone
Dexamethasone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [22] 13 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬
|
36 | HMED-IdeS | [1] Imlifidase Imlifidase | [1] Imlifidase
Imlifidase
💬
| - | - | [2] 64 64, 221 💬
|
37 | IDEC-C2B8, Ro 45-2294 | - | - | - | - | [1] 64 64 💬
|
38 | IdeS | [1] Imlifidase Imlifidase | [1] Imlifidase
Imlifidase
💬
| - | - | [2] 64 64, 221 💬
|
39 | IdeS (0.25 mg/kg) | [1] Imlifidase Imlifidase | [1] Imlifidase
Imlifidase
💬
| - | - | [1] 64 64 💬
|
40 | IdeS (0.50 mg/kg) | [1] Imlifidase Imlifidase | [1] Imlifidase
Imlifidase
💬
| - | - | [1] 64 64 💬
|
41 | Immunosuppressive treatment (eg, rituximab) | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 64 64 💬
|
42 | MabThera | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [22] 11 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 💬
|
43 | Magnesium | [1] Magnesium Magnesium | - | - | - | [15] 6 6, 11, 46, 64, 70, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298 💬
|
44 | MASP-2 antibody | [1] Narsoplimab Narsoplimab | [1] Narsoplimab
Narsoplimab
💬
| [1] MASP2 MASP2 💬
| [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | [3] 64 64, 66, 109 💬
|
45 | Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [1] Methylprednisolone
Methylprednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [46] 2 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
|
46 | Minirin | [1] Desmopressin Desmopressin | [1] Desmopressin
Desmopressin
💬
| [2] AVPR2 AVPR2, F8 💬
| [4] Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [2] 64 64, 288 💬
|
47 | Nanobody directed towards the human A1 domain of von Willebrand factor | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 64 64 💬
|
48 | Octaplas | [1] Plasma protein fraction (human) Plasma protein fraction (human) | - | - | - | [1] 64 64 💬
|
49 | Octaplas infusion | [1] Plasma protein fraction (human) Plasma protein fraction (human) | - | - | - | [1] 64 64 💬
|
50 | Octaplas SD | [1] Plasma protein fraction (human) Plasma protein fraction (human) | - | - | - | [1] 64 64 💬
|
51 | OctaplasLG® | - | - | - | - | [1] 64 64 💬
|
52 | Octaplas®LG | [1] Plasma protein fraction (human) Plasma protein fraction (human) | - | - | - | [1] 64 64 💬
|
53 | Octostim | - | - | - | - | [2] 64 64, 288 💬
|
54 | OMS721 | - | - | - | - | [3] 64 64, 66, 109 💬
|
55 | OMS721 100 mg/ml Injection solution, OMS00620646, OMS620646, MASP-2 Antibody | [1] Narsoplimab Narsoplimab | [1] Narsoplimab
Narsoplimab
💬
| [1] MASP2 MASP2 💬
| [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | [2] 64 64, 109 💬
|
56 | OMS721 185 mg/ml Injection solution, OMS00620646, OMS620646, MASP-2 Antibody | [1] Narsoplimab Narsoplimab | [1] Narsoplimab
Narsoplimab
💬
| [1] MASP2 MASP2 💬
| [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | [2] 64 64, 109 💬
|
57 | Plasma exchange (PE) | - | - | - | - | [1] 64 64 💬
|
58 | Pooled Plasma (Human), Solvent/Detergent Treated | - | - | - | - | [1] 64 64 💬
|
59 | PREDNISOLONE | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [42] 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
|
60 | Prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [45] 2 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 💬
|
61 | RADAMTS-13 | - | - | - | - | [1] 64 64 💬
|
62 | Recombinant A Disintegrin and Metalloproteinase Thrombospondin Type-1 Motifs 13 | - | - | - | - | [1] 64 64 💬
|
63 | Recombinant A Disintegrin and Metalloproteinase with Thrombospondin Type-1 | - | - | - | - | [1] 64 64 💬
|
64 | Recombinant A Disintegrin and Metalloproteinase with Thrombospondin Type-1 Motifs | - | - | - | - | [1] 64 64 💬
|
65 | Recombinant A Disintegrin and Metalloproteinase with Thrombospondin Type-1 Motifs 13 | - | - | - | - | [1] 64 64 💬
|
66 | Recombinant A Disintegrin And Metalloproteinase with Thrombospondin Type-1 Motifs 13 (rADAMTS13) | - | - | - | - | [1] 64 64 💬
|
67 | Recombinant ADAMTS13 | - | - | - | - | [1] 64 64 💬
|
68 | RITUXIMAB | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [48] 11 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|
69 | Romiplostim | [1] Romiplostim Romiplostim | [1] Romiplostim
Romiplostim
💬
| [1] MPL MPL 💬
| [2] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | [4] 60 60, 63, 64, 65 💬
|
70 | SHP 655 (BAX 930) | - | - | - | - | [1] 64 64 💬
|
71 | SHP655 | - | - | - | - | [1] 64 64 💬
|
72 | Standard of Care | - | - | - | - | [8] 6 6, 13, 49, 51, 63, 64, 79, 171 💬
|
73 | Standard Plasma | - | - | - | - | [1] 64 64 💬
|
74 | Standrd of Care treatment | - | - | - | - | [1] 64 64 💬
|
75 | Sulfate | [1] Sulfate ion Sulfate ion | - | - | - | [27] 2 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 85, 86, 96, 111, 218, 222, 224, 226, 265, 296, 297, 299 💬
|
76 | Sulfate, Magnesium | [2] Magnesium Magnesium, Sulfate ion | - | - | - | [1] 64 64 💬
|
77 | TAK-755 | - | - | - | - | [1] 64 64 💬
|
78 | TAK-755 or BAX930 or SHP655 | - | - | - | - | [1] 64 64 💬
|
79 | TAK-755 orBAX930 or SHP655 | - | - | - | - | [1] 64 64 💬
|
80 | Uniplas | - | - | - | - | [1] 64 64 💬
|
81 | Von willebrand factor | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [2] 64 64, 288 💬
|